CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis.
De Maria L, Terzi di Bergamo L, Conti A, Hayashi K, Pinzi V, Murai T, Lanciano R, Burneikiene S, Buglione di Monale M, Magrini SM, Fontanella MM.
De Maria L, et al.
Front Oncol. 2021 Mar 29;11:652646. doi: 10.3389/fonc.2021.652646. eCollection 2021.
Front Oncol. 2021.
PMID: 33854978
Free PMC article.
Median Overall Survival from CyberKnife treatment was 4.4 months for patients who underwent CyberKnife treatment alone, compared to 9.5 months for patients who underwent CyberKnife treatment plus chemotherapy. ...CONCLUSIONS: Reirradiation of recurrent malign …
Median Overall Survival from CyberKnife treatment was 4.4 months for patients who underwent CyberKnife treatment alone, compar …